DEMO

Log In | Sign Up



Bio-Rad Laboratories

Selected Articles

2025-08-13
GlobeNewswire
Demand for Global Mass Spectrometry Market Size to Surpass USD 14.49 Billion by 2034, Exhibit a CAGR of 7.70% - Comprehensive Research Report by Zion Market Research
2025-08-13
GlobeNewswire
Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge
2025-08-12
GlobeNewswire
In Vitro Diagnostics Market Size to Exceed USD 132.18 Bn by 2034
2025-08-12
GlobeNewswire
STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories
2025-08-12
GlobeNewswire
Virology and Bacteriology Business Analysis Report 2025 | Market to Reach $2.7 Billion by 2030 - Biopharmaceutical Pipeline Diversification Spurs Demand for Dual-Discipline Expertise and Platforms
2025-08-11
GlobeNewswire
U.S. Lateral Flow Assay Market Analysis Report 2025-2033 | Rise in Infectious Diseases Spurs Urgent Call for Stronger Surveillance, Prevention, and Diagnostic Systems
2025-08-08
GlobeNewswire
Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032 | Coherent Market Insights
2025-08-08
ETF Daily News
Mackenzie Financial Corp Buys 1,018 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
2025-08-07
PR Newswire UK
Autoimmunity Diagnostics Market worth US$8.98 billion by 2031 with 8.3% CAGR | MarketsandMarkets™
2025-08-06
GlobeNewswire
Lung Cancer Screening Market to Reach USD 7.44 Billion by 2032, Driven by LDCT Adoption and Growing High-Risk Population – SNS Insider

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. US0905722072 www.bio-rad.com